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Purpose: To review the current literature on safety, efficacy, and measures of surgeon and 
patient satisfaction with lidocaine hydrochloride gel as a tool for ocular anesthesia.
Methods: Pubmed search using keywords “lidocaine gel,” “ophthalmic,” and “surgery” and 
compiling cross-references. Twenty-six total references were reviewed, including 15 prospective 
randomized controlled trials (RCTs, total N = 933, average N = 62), 6 nonrandomized prospective 
studies (total N = 234, average N = 39), 2 animal studies, 1 microbiologic study, and 2 letters 
to the editor.
Results: The RCTs and nonrandomized prospective studies evaluated a number of measures 
including timing of onset of anesthesia, duration of anesthesia, intraoperative and postoperative 
pain, need for additional anesthetic applications, intracameral lidocaine levels, and adverse 
effects. Control groups received topical drops, subconjunctival anesthetic, retrobulbar anesthetic, 
or sham gel. Lidocaine gel was shown to be at least as effective for pain control as alternative 
therapies in all studies, with longer duration of action than topical drops. Patient and surgeon 
satisfaction were high, and adverse effects were rare and comparable to those for anesthetic 
drop formulations. Surgical settings included cataract, pterygium, trabeculectomy, strabismus, 
intravitreal injection, vitrectomy, and penetrating keratoplasty.
Conclusions: Lidocaine gel is a safe, effective, and potentially underutilized tool for ophthalmic 
surgery.
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Introduction
Local anesthesia for ophthalmic surgery was first introduced by Koller in 1884.1 
With the help of newly discovered topical cocaine, ophthalmic procedures could 
be performed more skillfully and more safely than with the conventional adjuncts 
of general anesthesia, hypnosis, or no anesthesia at all. Within weeks of Koller’s 
discovery of the topical efficacy of cocaine, other practitioners began to experiment 
with intraorbital injections of the drug. Surgeons soon realized that retrobulbar cocaine 
afforded unprecedented ability to produce total anesthesia and akinesia of the globe, 
and a wave of ophthalmic surgical advances ensued.2
Cocaine was lauded for its potent vasoconstrictive activity and its rapid blockade 
of sensory and motor nerves. The excitement over its retrobulbar use was tempered, 
however, by early reports of blindness, respiratory depression, and death with injection 
near the orbital apex.3
With the subsequent discovery of epinephrine and other pharmacologic advances, 
ophthalmic anesthesia became safer and more refined throughout the 20th century. Clinical Ophthalmology 2009:3 602
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In the 1930s, procaine and lidocaine were found to be 
cheaper and more stable than cocaine. In 1949, Atkinson 
reported that the addition of hyaluronidase could facilitate 
safe, long-lasting, large-volume retrobulbar nerve blockade.4 
Variations on this technique continued to dominate anesthesia 
for intraocular surgery through the 1970s and 1980s.
The first cataract phacoemulsification in 1972 forecast a 
trend of faster, cleaner ophthalmic surgery through smaller 
and smaller incisions. As the tools improved and the paradigm 
shifted, many surgeons found themselves able to return to 
purely topical anesthetic techniques in order to mitigate the 
discomfort and risks associated with retrobulbar or peribulbar 
injection.
Topical anesthetics
Topical anesthetics work by reversibly blocking sodium 
channels and preventing propagation of painful nerve 
impulses in the cornea, conjunctiva, and sclera. In the 
cornea, nerve endings are superficial and protected only by 
the tear film and by a thin layer of stratified epithelium that is 
permeable to lipid- and aqueous-soluble molecules. Nerves 
in the conjunctiva are covered by nonkeratinized stratified 
epithelium, readily penetrated by topical anesthetics if pH 
conditions are optimal.5
Tetracaine is available in a non-preserved form and 
penetrates an intact tear film if formulated to match the pH 
(7.6 to 7.8) of the tear film. Lidocaine behaves in a similar 
fashion. Without pH-adjusting additives, these anesthetics 
typically cause significant stinging on application and 
carry reduced patient acceptability in office or emergency 
department settings. Proparacaine and benoxinate contain the 
bacteriocide benzalkonium chloride, which acts to disrupt 
the lipid and mucous layers of the tear film and allow these 
anesthetics more direct access to corneal and conjunctival 
nerve endings via the unprotected epithelium.5
Topical anesthetic drops are convenient, typically safe, 
and provide rapid onset of anesthesia. Corneal anesthesia is 
especially rapid and complete. Drawbacks to topical drops 
include incomplete anesthesia of the conjunctiva and sclera 
with a single application, potential toxicity to the corneal 
epithelium, and the need for multiple drop applications over 
the course of a given ophthalmic procedure.
Gel formulations of topical anesthetics have been in use 
in the fields of urology and otolaryngology for many years; 
due to their viscous qualities they are favored for anesthesia of 
mucous membranes and other areas where high flow of saliva, 
urine, and secretions may dilute an aqueous anesthetic and 
reduce its effectiveness. It follows that aqueous anesthetics 
would be subject to the same diluent effect in the eye, with 
ongoing tear film turnover and the use of irrigants during 
ophthalmic surgery.3
Over the last 10 years a number of reports have been 
submitted on the utility of gel anesthetic, specifically 
lidocaine gel, for ocular procedures. The purpose of this 
paper is to review the literature on lidocaine gel in ophthalmic 
surgery, and comment on overall safety, efficacy, and patient 
acceptability of this potentially underutilized surgical tool.
Methods
A Pubmed search was conducted using the terms “lidocaine 
gel” and “ophthalmic” and restricted to English-language 
studies. There was no restriction on year of publication. 
Twenty-six listings were initially returned, and bibliographic 
references from each study were explored and added to the 
review. Articles on pharmacokinetics, basic physiology, and 
basic pharmacology were omitted from the review. A total 
of 25 clinically relevant studies were included for analysis 
and discussion.
Results
Of the 25 relevant studies, 15 were prospective randomized 
controlled trials. Six were nonrandomized prospective 
studies, and 1 was a large retrospective case series. 
Two animal studies and 1 microbiologic study were included. 
Two letters to the editor are also referenced.
The prospective studies on lidocaine gel in ophthalmic 
surgery covered a wide variety of operative situations 
and there were relevant data to review for each of the 
ophthalmic surgical subspecialties. Eight studies addressed 
the use of lidocaine gel in cataract surgery,6–13 4 in 
pterygium surgery,14–17 2 in trabeculectomy/Ahmed valve 
implantation,18,19 and 1 on phaco/trabeculectomy combination 
procedures.20 There were 2 papers on lidocaine gel for 
intravitreal injection,21,22 and 1 on vitrectomy.23 In addition 
there was 1 paper each on lidocaine gel in the setting of 
penetrating keratoplasty,24 strabismus surgery,25 and chalazion 
excision.26
randomized controlled trials (rCT)
Salient points from the  15 prospective randomized 
controlled trials are summarized in Table 1. In each of these 
RCTs, lidocaine gel 2% was compared to topical tetracaine 
drops, subconjunctival injection, retrobulbar injection, 
sham gel, or another anesthetic modality. Clinical endpoints 
included patient-reported pain scores on a visual analog 
scale or verbal pain score during anesthetic instillation, Clinical Ophthalmology 2009:3 603
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pain during surgery, and/or pain in the postoperative period. 
Other primary clinical endpoints included time to onset of 
anesthesia and duration of anesthesia. Secondary measures 
included subjective patient satisfaction, subjective surgeon 
satisfaction, need for additional anesthetic, and changes in 
intraoperative vital signs. The 15 RCTs ranged in size from 
14 to 209 subjects. A total of 933 patients were included in 
these 15 studies, with an average N of 62. Two of the RCTs 
were double-blinded;7,27 the remaining 13 were unblinded but 
considered to be high-quality with the exception of 2 that 
were possibly underpowered (N  20).22,25 Meta-analysis was 
not carried out on the studies due to their variable endpoints, 
differing surgical/procedural environments, and variable 
control groups across the studies.
Subjective pain
All 13 RCTs which measured intraoperative or postoperative 
pain with lidocaine gel vs another anesthetic modality relied 
upon patient reported pain levels, using typical verbal pain 
score (VPS, 0 to 10, with 0 being no discomfort and 10 being 
excruciating pain) or visual analog scale (VAS, 0 to 10) 
measures. Eight out of 13 RCTs reported no significant 
difference in pain scores between the lidocaine gel group 
and the corresponding control group. Five out of 13 of 
these studies indicated a statistically significantly lower 
pain score in the lidocaine gel group compared with the 
control group (P values  0.001 to  0.01). Three studies 
reported a statistically significantly lower pain level at the 
time of administration of lidocaine gel vs subconjunctival 
lidocaine or retrobulbar block for Ahmed valve implantation 
(Rebollada et al P  0.001),18 pterygium excision (Oksuz et 
al P  0.01),16 or chalazion excision (Li et al P  0 .001).26 
One study (Soliman et al)12 found that patients reported 
a statistically significantly higher pain level at the time 
of administration of lidocaine gel vs administration of 
bupivicaine drops or benoxinate drops before cataract surgery 
(P  0 .001).
Time to onset and duration of anesthesia
Busbee et al27 showed that 88% to 92% of patients 
became anesthetic to conjunctival pinching with varying 
concentrations (1.5%, 2.5%, and 3.5%) of lidocaine gel 
within 5 minutes, while 22% of patients receiving sham gel 
also reported anesthesia to conjunctival pinching. In this 
study there was a dose-dependent variation in duration 
of anesthesia, with lidocaine gel 3.5% producing the 
longest duration of anesthesia (P  0.001). Barequet et al8 
demonstrated that both lidocaine gel and tetracaine drops 
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produced equally adequate anesthesia (as measured with a 
Cochet-Bonnet anesthesiometer) at 5 minutes post-instillation 
and also when measured postoperatively.
Need for additional anesthetic
Five RCTs compared lidocaine gel with control groups 
and reported the total number of additional anesthetic 
applications required for patient comfort during cataract 
extraction,8,12 pterygium excision,17 strabismus surgery,25 and 
trabeculectomy.19 Four of these 5 studies demonstrated that 
the use of lidocaine gel as the primary preoperative anesthetic 
resulted in a statistically significantly lower number of 
supplemental anesthetic applications required during surgery 
to maintain patient comfort (P  0.001 to  0.01). One of 
the studies showed no significant difference (lidocaine gel 
vs retrobulbar block for trabeculectomy).19
Prospective nonrandomized trials
The 6 nonrandomized prospective trials evaluating the 
use of lidocaine gel for ocular surgery ranged in size from 
15 to 100 subjects, with an average N of 39. These studies 
evaluated similar primary and secondary outcome measures 
as the randomized controlled trials, including intraoperative/
postoperative pain score, and need for additional anesthetic 
applications. See Table 2 for detailed information.
Patient and surgeon satisfaction
Several nonrandomized and randomized prospective 
trials tracked patient and surgeon satisfaction with 
the surgical experience under lidocaine gel anesthesia. 
Data were collected via subjective report and numeric 
scales. In a nonrandomized study of 15 patients undergoing 
repeat penetrating keratoplasty under topical lidocaine gel 
anesthesia (plus intracameral lidocaine and IV sedation) 
Segev et al reported that on a scale of 0 to 5 (0 = not at all 
satisfied, 5 = very satisfied), average patient satisfaction was 
4.67 and average surgeon satisfaction was 4.67. They report 
that 14/15 patients preferred their surgical experience with 
topical lidocaine to their previous experience with retrobulbar 
injection.24 In their RCT studying lidocaine gel use in cataract 
surgery, Soliman et al indicate that 93.3% of patients reported 
they were “satisfied” with their surgical experience under 
lidocaine gel anesthesia, compared with 83.3% of patients 
who received bupivacaine 0.5% drops and 33.3% of patients 
who received benoxinate 0.4% drops.12 In a series of 100 
cataract extractions performed with lidocaine gel anesthesia, 
Assia et al noted improved lubrication of surgical instru-
ments and easier entry and exit through surgical wounds.6 
Finally, in his letter to the editor of Journal of Cataract and 
Refractive Surgery, Kirber noted excellent personal results 
in a series of cataract extractions performed with a 50/50 
dilution of lidocaine 2% with balanced salt solution, includ-
ing potent patient anesthesia and a similar improvement in 
instrument facility/lubrication.9
intracameral lidocaine levels
In a nonrandomized prospective study of cataract surgery 
patients, Kwok et al demonstrated a strong correlation 
between duration of contact of lidocaine gel with the ocular 
surface and intracameral lidocaine levels measured by high 
performance liquid chromatography. However, they did 
not show any statistically significant correlation between 
intracameral lidocaine levels and pain score.10 In their RCT 
(also studying cataract surgery patients), Bardocci et al 
demonstrated that patients who received lidocaine gel 2% had 
significantly higher intracameral lidocaine levels than those 
receiving lidocaine 4% drops. This study similarly found no 
significant correlation between intracameral lidocaine levels 
and VPS pain score.7
Adverse effects and safety
The prospective randomized controlled trial by Busbee et al 
(examining timing of onset and duration of anesthesia with 
varying concentrations of lidocaine gel) specifically defined 
“adverse events” as corneal staining, conjunctival hyperemia, 
and/or pain with administration. They found the adverse 
event rate as defined here to be 2% to 6%, comparable across 
all 209 subjects and across all treatment groups (lidocaine 
gel 1.5%, 2.5%, 3.5%, and sham gel).27 The remainder of the 
human prospective trials reported an adverse event rate that 
was similarly low and not significantly different from controls 
or commonly reported side effects with topical anesthetic 
drops. Kozak et al demonstrated a statistically significantly 
higher rate of subconjunctival hemorrhage and chemosis 
among patients receiving subconjunctival lidocaine vs those 
receiving topical lidocaine gel prior to intravitreal injection 
(P  0.001), with no difference in pain scores between the 
two groups (P = 0.82).22 Likewise, Zabriskie et al reported 
no difference in pain scores but a significantly higher rate 
of chemosis, subconjunctival hemorrhage, and eyelid 
hemorrhage in patients receiving retrobulbar injection vs 
lidocaine gel for trabeculectomy (P  0.03).19
Tissue toxicity
In a rabbit study, Barequet et al demonstrated that neither 
topical lidocaine gel placed in the fornices of rabbit eyes nor Clinical Ophthalmology 2009:3 606
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small volumes of lidocaine gel injected directly into the anterior 
chamber produced any significant clinical or histopathological 
alteration of ocular tissues.8 Schellini et al performed a series 
of anterior chamber injections into rabbit eyes with lidocaine 
gel 2% with preservative, lidocaine gel without preserva-
tive, preservative alone, and saline alone. They showed no 
significant difference across the groups in clinical, ultrastruc-
tural, or morphometric evaluations of the rabbit corneas, and no 
significant histological effects on corneal endothelial cells.29
effects on preoperative antisepsis
Boden et al performed a microbiologic study on the interaction 
between lidocaine gel and povidone iodine, the most commonly 
used preoperative ocular antiseptic in the US. The authors 
inoculated sets of plates of blood agar with Staphylococcus 
aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa, 
and Haemophilus influenza, and applied either lidocaine gel 
2% alone, lidocaine gel plus povidone iodine 5%, or povidone 
iodine alone to each set of plates. They reserved a set of plates 
for each organism with inoculum alone as a control. The plates 
were then cultured under standard conditions. The authors 
demonstrated that the number of colony forming units (CFUs) 
was similar in the control group (inoculum only), the lidocaine-
only group, and the lidocaine + povidone group for S. aureus, 
S. epidermidis, and P . aeruginosa. Each set of plates in these 
groups grew between 200 and 300 CFUs, while the povidone + 
inoculum group for all 4 organisms grew only 0 to 6 CFUs.30 
These results imply a decreased antimicrobial effectiveness 
of povidone iodine in the presence of lidocaine gel, which 
potentially could increase the risk for acute postoperative 
infection in ocular surgery performed under lidocaine gel 
anesthesia. On the clinical side, in a retrospective review of 
15,920 cataract extractions performed at a single institution, 
Miller et al reported an incidence of 7/15,920 cases of acute 
postoperative endophthalmitis (0.04%). This rate is consistent 
with other large reports in the literature, and is notable for the 
fact that 2 out of the 7 cases were performed under lidocaine 
gel topical anesthesia.11 The paper by Miller et al has been 
referenced numerous times in discussions that lidocaine gel 
may increase the risk of acute postoperative endophthalmitis, 
but there has been no other large scale study or statistically 
significant data published to date which establishes a higher 
rate of acute postoperative endophthalmitis under gel 
anesthesia versus other anesthetic modalities.
Conclusions
Thanks to the work of pioneers throughout the 19th and 
20th centuries, ophthalmic surgeons today have a wide 
variety of anesthetic tools at their disposal. Depending on the 
surgical procedure to be performed, patient characteristics, 
and surgeon factors, the preferred anesthetic modality 
may include general anesthesia, iv sedation, retrobulbar or 
peribulbar blockade, topical anesthesia, or any combination 
thereof. There will always be cases where general anesthesia 
confers extra safety (pediatric, mentally retarded, and 
demented populations to name a few examples). Likewise 
there are some scenarios where total akinesia and anesthesia 
is paramount and retrobulbar injection provides the safest 
and most stable surgical environment.
With advances in surgical techniques and instrumenta-
tion, there has been a general trend toward smaller incisions 
and less invasive maneuvers in ophthalmic surgery. This 
has been accompanied over the last 25 years by a renewed 
interest in topical anesthetic techniques, which in many 
cases enhance patient comfort and reduce the inherent risks 
of retrobulbar and peribulbar injection. These risks include 
but are not limited to ocular penetration and perforation 
(approximately 1 in 1000), retrobulbar hemorrhage (1% to 
3%), central nervous depression (1 per 350 to 500 cases)33 
and pain with injection requiring substantial premedication 
by the anesthesiologist.
The series of papers presented here indicate that lidocaine 
gel is at least as effective and often more effective than widely 
available topical anesthetic drops for treating and preventing 
cataract surgery-related pain. Where lidocaine gel is compared 
to retrobulbar and subconjunctival anesthesia for a variety 
of non-cataract procedures (pterygia, glaucoma surgery, 
strabismus, vitreoretinal surgery, and corneal transplant), pain 
control has been shown to be at least as good, and with fewer 
adverse effects. There have been a limited number of studies 
in these areas, however, and with relatively small groups 
of patients. The 15 randomized controlled trials discussed 
here were determined to be of moderate to high quality, with 
some being underpowered. The 6 nonrandomized prospective 
trials do not offer additional statistical support for the use 
of lidocaine gel but the data provided is fairly convincing of 
the product’s utility.
Patient and surgeon satisfaction with the use of lidocaine 
gel has been high, with patients reporting improved comfort 
and several practitioners noting improved instrument 
lubrication and facility of surgery due to the gel’s physical 
characteristics.
A handful of animal studies have been carried out to 
demonstrate the safety of lidocaine gel and its lack of significant 
clinical or histopathological adverse effects on ocular tissues. 
On the other hand, questions have been raised as to the reduced Clinical Ophthalmology 2009:3 608
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efficacy of povidone iodine antisepsis when applied after 
lidocaine gel as part of the preoperative regimen, which could 
potentially produce a substantial increase in risk of acute post-
operative infection. In our search of the literature we found one 
large case series (Miller et al)11 which suggests an increased 
risk of acute postoperative endophthalmitis with lidocaine gel 
anesthesia, but the overall incidence is very low (0.04%) and 
it is difficult to draw any statistically significant conclusions 
about the role of the anesthetic. The paper by Miller has been 
referenced numerous times in discussions on lidocaine gel and 
endophthalmitis risk, but to our knowledge there has been no 
other large case series or presentation of statistically significant 
data (other than the microbiological study discussed here) which 
indicates a real increase in the risk. Furthermore, until recently 
the majority of lidocaine gel used for ophthalmic surgery was 
not originally manufactured for this use and did not come 
packaged in sterile dropper form (which may have increased 
the risk of contamination). Now that the gel formulations are 
available in sterile packaging and in a format more suitable for 
ophthalmic application, the risk of postoperative infection may 
be mitigated even further. Other means of decreasing the risk 
of contamination and increasing the effectiveness of povidone 
iodine antisepsis could include the copious irrigation of the 
conjunctival fornices after adequate preoperative contact with 
the gel and prior to povidone instillation.
In the overall, lidocaine gel appears to be a safe and 
highly efficacious tool for ocular anesthesia, with high patient 
and surgeon satisfaction when the product is employed 
appropriately. Based upon our findings in the literature we 
would support its use. More data are needed on lidocaine gel 
and acute postoperative endophthalmitis risk, as a perceived 
increase in the risk is likely the most significant deterrent to 
its acceptance and use by more ophthalmic surgeons.
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